Myelodysplastic Syndromes (MDS)
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes
Myelodysplastic syndrome/Myeloproliferative neoplasms (MDS/MPNs) are molecularly complex, clinically heterogeneous diseases that exhibit proliferative and dysplastic features. Diagnostic criteria use clinical, pathologic, and genomic features to distinguish between disease entities, though considerable clinical and genetic overlap persists. MDS/MPNs are associated with a poor prognosis, save for MDS/MPN with ring sideroblasts and thrombocytosis, which can behave more indolently.
Venetoclax
Venetoclax Venetoclax: Venetoclax is used to treat chronic lymphocytic leukemia or small lymphocytic leukemia in adults.
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study
Objectives: Evidence-based guidelines call for integration of palliative care within oncology from diagnosis. Misperceptions about palliative care have impeded implementation. Prior research has not examined perceptions about 'palliative care' versus 'supportive care' among patients and caregivers to whom this care is introduced routinely as part of comprehensive cancer care.
Haploidentical Transplant for MDS
ONS 2021 Symposium Materials
Thank you for attending our ONS 2021 Satellite Symposium!
Please find below, slides of each of the program's presentation, as well as, pdf versions of some of our materials that are helpful to both Patients and Health Professionals.
MDS Toolkit
Health Professional accredited and non-accredited webinars
Nathan Punwani, MD, MPH
What's My Mutation? Understanding the Risks for Low/Moderate Risk MDS Patients: Spring 2021 Conference
Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
Disease relapse remains a major cause of treatment failure in patients receiving allogeneic hematopoietic cell transplantation (alloHCT) for high-risk acute leukemias or myelodysplastic syndromes
